Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06881173
NA

The Effectiveness of Bu Zhong Yi Qi Tang in Patients with Myasthenia Gravis

Sponsor: Cheng, yu-ting

View on ClinicalTrials.gov

Summary

Research Background: According to the Myasthenia Gravis Foundation of America (MGFA, 2015), the estimated prevalence of myasthenia gravis is 14-20 per 100,000 people, with a higher prevalence in young female individuals compared to males. However, as individuals age, especially after the age of 50, the prevalence in males becomes higher than in females. myasthenia gravis patients often experience varying degrees of disability, leading to the need for long-term medical care, medication, and lifestyle adjustments. This also gives rise to subsequent challenges in caregiving, affecting both the patients' families and society.

Official title: Efficacy of Meridian Energy and Heart Rate Variability in Patients with Ocular Myasthenia Gravis by Using Chinese and Western Medicine Treatment

Key Details

Gender

All

Age Range

20 Years - Any

Study Type

INTERVENTIONAL

Enrollment

112

Start Date

2022-06-14

Completion Date

2025-06-13

Last Updated

2025-03-20

Healthy Volunteers

No

Interventions

DRUG

Bu Zhong Yi Qi Tang

The experimental group took 15g of Buzhong Yiqi Decoction concentrated powder, 3 times a day, 1 packet each time.

DRUG

caramel dyed starch placebo

The control group took 15 grams of caramel dyed starch placebo, 1 pack at a time, 3 times a day.

Locations (1)

Shin Kong Wu Ho-Su Memorial Hospital

Taipei, Taiwan